Order Article Reprints

Eberhardt KA, Dewald F, Heger E, Gieselmann L, Vanshylla K, Wirtz M, Kleipass F, Johannis W, Schommers P, Gruell H, et al. Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms. 2021; 9(4):733. https://doi.org/10.3390/microorganisms9040733

Eberhardt, Kirsten Alexandra, Felix Dewald, Eva Heger, Lutz Gieselmann, Kanika Vanshylla, Maike Wirtz, Franziska Kleipass, Wibke Johannis, Philipp Schommers, Henning Gruell, and et al. 2021. "Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG" Microorganisms 9, no. 4: 733. https://doi.org/10.3390/microorganisms9040733

Eberhardt, K. A., Dewald, F., Heger, E., Gieselmann, L., Vanshylla, K., Wirtz, M., Kleipass, F., Johannis, W., Schommers, P., Gruell, H., Brensing, K. A., Müller, R.-U., Augustin, M., Lehmann, C., Koch, M., Klein, F., & Di Cristanziano, V. (2021). Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms, 9(4), 733. https://doi.org/10.3390/microorganisms9040733